|
|
|
|
|
Leonard B. Bacharier, M.D.
|
|
Associate Professor of Pediatrics
Clinical Director, Division of Pediatric Allergy, Immunology, & Pulmonary Medicine
Allergy, Immunology and Pulmonary Medicine
Cystic Fibrosis Center
Patient Oriented Research
Dr. Bacharier is a member and Clinical Director of the Division of Allergy and Pulmonary Medicine. He received his undergraduate degree in biophysics from The Johns Hopkins University and his medical degree from Washington University School of Medicine. Dr. Bacharier was an intern and resident in pediatrics at St. Louis Children's Hospital. He was a fellow in Pediatric Allergy and Immunology at Children's Hospital, Boston and Harvard Medical School. He joined the faculty of Washington University in 1998. He is board certified in Pediatrics and Allergy and Clinical Immunology. He is a member of several organizations including the American Academy of Allergy, Asthma and Immunology and the American Thoracic Society. He was a recipient of the 2005 Samuel R. Goldstein Leadership Award in Medical Student Education from Washington University School of Medicine.
Dr. Bacharier's research focuses on childhood asthma. Specifically, he is co-principal investigator for the NHBLI’s AsthmaNet, a multi-centered network examining novel therapeutic approaches to asthma in children and adults. He is an investigator in the Childhood Asthma Research and Education (CARE) Network, an NHLBI-funded multi-centered network examining novel therapeutic strategies in children with asthma. He is a co-investigator in the Childhood Asthma Management Program, a multi-centered prospective trial examining the effects of early treatment of asthma on lung growth. He also serves as Co-Principal Investigator of a study examining the role of early infection with Respiratory Syncytial Virus upon the subsequent development of asthma.
|
Leonard B. Bacharier, M.D.
|
|
Associate Professor of Pediatrics
Clinical Director, Division of Pediatric Allergy, Immunology, & Pulmonary Medicine
Allergy, Immunology and Pulmonary Medicine
Cystic Fibrosis Center
Patient Oriented Research
Dr. Bacharier is a member and Clinical Director of the Division of Allergy and Pulmonary Medicine. He received his undergraduate degree in biophysics from The Johns Hopkins University and his medical degree from Washington University School of Medicine. Dr. Bacharier was an intern and resident in pediatrics at St. Louis Children's Hospital. He was a fellow in Pediatric Allergy and Immunology at Children's Hospital, Boston and Harvard Medical School. He joined the faculty of Washington University in 1998. He is board certified in Pediatrics and Allergy and Clinical Immunology. He is a member of several organizations including the American Academy of Allergy, Asthma and Immunology and the American Thoracic Society. He was a recipient of the 2005 Samuel R. Goldstein Leadership Award in Medical Student Education from Washington University School of Medicine.
Dr. Bacharier's research focuses on childhood asthma. Specifically, he is co-principal investigator for the NHBLI’s AsthmaNet, a multi-centered network examining novel therapeutic approaches to asthma in children and adults. He is an investigator in the Childhood Asthma Research and Education (CARE) Network, an NHLBI-funded multi-centered network examining novel therapeutic strategies in children with asthma. He is a co-investigator in the Childhood Asthma Management Program, a multi-centered prospective trial examining the effects of early treatment of asthma on lung growth. He also serves as Co-Principal Investigator of a study examining the role of early infection with Respiratory Syncytial Virus upon the subsequent development of asthma.
|
|
|
|
|
|
|
1. Bacharier L, Horner CC, Figueroa ED, DeMuth K, Beigelman A, Borgmeyer AE, Gyr P, Silver E, Kertz LC, Thatayatikom S. Allergic Diseases. In The Washington Manual of Pediatrics. Lippincott Williams and Wilkins, 2009.
2. Rivera-Spoljaric K and Bacharier L. Pulmonary Diseases. In The Washington Manual of Pediatrics. Lippincott Williams and Wilkins, 2009.
3. Bacharier LB and Strunk RC: Asthma in the Older Child. In Leung DYM, Sampson H, Geha R, Szefler S (eds) Pediatric Allergy: Principles and Practice, 2nd Edition, Mosby, 2009 (in press).
4. Knuffman JE, Sorkness CA, Lemanske RF, Mauger DT, Boehmer SJ, Martinez FD, Bacharier LB, Strunk RC, Szefler SJ, Zeiger RS, Taussig LM. Phenotypic Predictors of Long-Term Response to Inhaled Corticosteroids and Leukotriene Modifier Therapies in Pediatric Asthma. J Allergy Clin Immunol 2009; 123:411-6.
5. American Lung Associatiaton Asthma Clinical Research Centers, Mastronarde JG, Anthonisen NR, Castro M, Holbrook JT, Leone FT, Teague WG, Wise RA (Bacharier LB, Co-Investigator). Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 2009; 360:1487-99.
6. Rivera-Spoljaric K, Chinchilli VM, Camera LJ, Zeiger RS, Paul IM, Phillips BR, Taussig LM, Strunk RC, Bacharier LB. Signs and Symptoms that Precede Wheezing in Children with Moderate-to-Severe Intermittent Wheezing. J Pediatr 2009; 154(6):877-81.e4. Epub 2009 Mar 25.
7. Bacharier LB, Guilbert TW, Zeiger RS, Strunk RC, Morgan WJ, Lemanske RF, Moss M, Szefler SJ, Krawiec M, Boehmer S, Mauger D, Taussig LM, Martinez FD. Patient Characteristics Associated with Improved Outcomes with Use of an Inhaled Corticosteroid in Preschool Children at Risk for Asthma. J Allergy Clin Immunol 2009; 123(5):1077-82, 1082.e1-5. Epub 2009 Feb 23.
8. Strunk RC, Sternberg AL, Szefler SJ, Zeiger RS, Bender B, Tonascia J; Childhood Asthma Management Program (CAMP) Research Group (Bacharier LB, Co-Investigator). Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents. J Pediatr. 2009 May;154(5):682-7. Epub 2009 Jan 23.
9. Beigelman A, MAuger DT, Phillips BR, Zeiger RS, Taussig LM, Strunk RC, Bacharier LB. Elevated Exhaled Nitric Oxide Levels Increase Risk of Respiratory Tract Illness in Preschool-aged Children with Moderate-to-Severe Wheezing. Ann Allergy Asthma Immunol 2009; in press.
10. Paul IM, Camera L, Zeiger RS, Guilbert RW, Bacharier LB, Taussig LM, Morgan WH, Covar RA, Krawiec M, Bloomberg GR, Mauger DT. Relationship between infant weight gain and later asthma. Pediatr Allergy Immunol 2009; in press.
1. Bacharier L, Horner CC, Figueroa ED, DeMuth K, Beigelman A, Borgmeyer AE, Gyr P, Silver E, Kertz LC, Thatayatikom S. Allergic Diseases. In The Washington Manual of Pediatrics. Lippincott Williams and Wilkins, 2009.
2. Rivera-Spoljaric K and Bacharier L. Pulmonary Diseases. In The Washington Manual of Pediatrics. Lippincott Williams and Wilkins, 2009.
3. Bacharier LB and Strunk RC: Asthma in the Older Child. In Leung DYM, Sampson H, Geha R, Szefler S (eds) Pediatric Allergy: Principles and Practice, 2nd Edition, Mosby, 2009 (in press).
4. Knuffman JE, Sorkness CA, Lemanske RF, Mauger DT, Boehmer SJ, Martinez FD, Bacharier LB, Strunk RC, Szefler SJ, Zeiger RS, Taussig LM. Phenotypic Predictors of Long-Term Response to Inhaled Corticosteroids and Leukotriene Modifier Therapies in Pediatric Asthma. J Allergy Clin Immunol 2009; 123:411-6.
5. American Lung Associatiaton Asthma Clinical Research Centers, Mastronarde JG, Anthonisen NR, Castro M, Holbrook JT, Leone FT, Teague WG, Wise RA (Bacharier LB, Co-Investigator). Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 2009; 360:1487-99.
6. Rivera-Spoljaric K, Chinchilli VM, Camera LJ, Zeiger RS, Paul IM, Phillips BR, Taussig LM, Strunk RC, Bacharier LB. Signs and Symptoms that Precede Wheezing in Children with Moderate-to-Severe Intermittent Wheezing. J Pediatr 2009; 154(6):877-81.e4. Epub 2009 Mar 25.
7. Bacharier LB, Guilbert TW, Zeiger RS, Strunk RC, Morgan WJ, Lemanske RF, Moss M, Szefler SJ, Krawiec M, Boehmer S, Mauger D, Taussig LM, Martinez FD. Patient Characteristics Associated with Improved Outcomes with Use of an Inhaled Corticosteroid in Preschool Children at Risk for Asthma. J Allergy Clin Immunol 2009; 123(5):1077-82, 1082.e1-5. Epub 2009 Feb 23.
8. Strunk RC, Sternberg AL, Szefler SJ, Zeiger RS, Bender B, Tonascia J; Childhood Asthma Management Program (CAMP) Research Group (Bacharier LB, Co-Investigator). Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents. J Pediatr. 2009 May;154(5):682-7. Epub 2009 Jan 23.
9. Beigelman A, MAuger DT, Phillips BR, Zeiger RS, Taussig LM, Strunk RC, Bacharier LB. Elevated Exhaled Nitric Oxide Levels Increase Risk of Respiratory Tract Illness in Preschool-aged Children with Moderate-to-Severe Wheezing. Ann Allergy Asthma Immunol 2009; in press.
10. Paul IM, Camera L, Zeiger RS, Guilbert RW, Bacharier LB, Taussig LM, Morgan WH, Covar RA, Krawiec M, Bloomberg GR, Mauger DT. Relationship between infant weight gain and later asthma. Pediatr Allergy Immunol 2009; in press.
|
|
|